Clinic
Asmg Sand Springs
Asmg Sand Springs was paid $2.05M by Medicaid between Jan 2018 and Dec 2024, across 38 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 38% of everything it billed.
33Billing provider infoASMG SAND SPRINGS
SAND SPRINGS, OK 74063
SAND SPRINGS, OK 74063
33aNPI1902140056assigned 11/15/2012
33bProvider typePrimary Care Clinic/Center
28Total paid$2.05M
24GClaims50,804
24DCodes billed38
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Primary Care Clinic/Center providers in Oklahoma
Rank by total paid#7 of 86
Median peer was paid$175K
This provider vs. median12×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,652 | $230K | |
| 2019 | 5,908 | $255K | |
| 2020 | 5,091 | $189K | |
| 2021 | 7,855 | $293K | |
| 2022 | 10,719 | $436K | |
| 2023 | 10,650 | $421K | |
| 2024incomplete | 4,929 | $230K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 38% | 11,308 | 10,478 | $774K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 37% | 7,690 | 7,200 | $767K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 4.9% | 1,068 | 1,068 | $100K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 4.0% | 559 | 559 | $81K |
| 99406 | 2.5% | 3,865 | 3,479 | $51K | |
| 96127 | 2.1% | 10,982 | 9,895 | $44K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 2.1% | 2,393 | 2,306 | $43K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.4% | 276 | 275 | $28K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.1% | 1,341 | 1,332 | $23K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.1% | 2,541 | 2,399 | $22K |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,549 | 3,411 | $17K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 344 | 331 | $15K |
26 more codes
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 169 | $14K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 150 | $14K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 644 | $13K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 378 | $12K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 78 | $8K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 296 | $6K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 55 | $6K |
| 90686 | <1% | 634 | $4K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 97 | $3K |
| 99173 | <1% | 707 | $2K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 52 | $2K |
| 99384 | <1% | 12 | $1K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 14 | $1K |
| 87634 | <1% | 12 | $792.84 | |
| 81025 | <1% | 82 | $610.31 | |
| 99490 | Ccm add 20min | <1% | 88 | $343.38 |
| 99407 | <1% | 14 | $325.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 30 | $281.70 |
| 90674 | <1% | 14 | $237.67 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 14 | $190.54 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 16 | $83.20 |
| 96160 | <1% | 1,172 | $71.32 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 48 | $41.77 |
| 90734 | 0% | 44 | $0.00 | |
| 90670 | 0% | 12 | $0.00 | |
| 90651 | 0% | 56 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFERRELL, KELLY (MANAGER)